This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iervolino, A.
Right arrow Articles by Perrotti, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iervolino, A.
Right arrow Articles by Perrotti, D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2002, p. 2255-2266, Vol. 22, No. 7
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.7.2255-2266.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis

Angela Iervolino,1 Giorgia Santilli,1,2 Rossana Trotta,1 Clara Guerzoni,3 Vincenzo Cesi,1 Anna Bergamaschi,3 Carlo Gambacorti-Passerini,4,5 Bruno Calabretta,1 and Danilo Perrotti1*

Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107,1 Department of Oncology and Neuroscience, University G. D'annunzio, Chieti 66100,2 Department of Biomedical Sciences, Section of General Pathology, University of Modena, Modena 41100,3 Experimental Oncology, NCI, Milan 20133,4 Hematology Section, S. Gerardo Hospital, Monza 20052, Italy5

Received 29 May 2001/ Returned for modification 27 July 2001/ Accepted 17 December 2001

hnRNP A1 is a nucleocytoplasmic shuttling heterogeneous nuclear ribonucleoprotein that accompanies eukaryotic mRNAs from the active site of transcription to that of translation. Although the importance of hnRNP A1 as a regulator of nuclear pre-mRNA and mRNA processing and export is well established, it is unknown whether this is relevant for the control of proliferation, survival, and differentiation of normal and transformed cells. We show here that hnRNP A1 levels are increased in myeloid progenitor cells expressing the p210BCR/ABL oncoprotein, in mononuclear cells from chronic myelogenous leukemia (CML) blast crisis patients, and during disease progression. In addition, in myeloid progenitor 32Dcl3 cells, BCR/ABL stabilizes hnRNP A1 by preventing its ubiquitin/proteasome-dependent degradation. To assess the potential role of hnRNP A1 nucleocytoplasmic shuttling activity in normal and leukemic myelopoiesis, a mutant defective in nuclear export was ectopically expressed in parental and BCR/ABL-transformed myeloid precursor 32Dcl3 cells, in normal murine marrow cells, and in mononuclear cells from a CML patient in accelerated phase. In normal cells, expression of this mutant enhanced the susceptibility to apoptosis induced by interleukin-3 deprivation, suppressed granulocytic differentiation, and induced massive cell death of granulocyte colony-stimulating factor-treated cultures. In BCR/ABL-transformed cells, its expression was associated with suppression of colony formation and reduced tumorigenic potential in vivo. Moreover, interference with hnRNP A1 shuttling activity resulted in downmodulation of C/EBP{alpha}, the major regulator of granulocytic differentiation, and Bcl-XL, an important survival factor for hematopoietic cells. Together, these results suggest that the shuttling activity of hnRNP A1 is important for the nucleocytoplasmic trafficking of mRNAs that encode proteins influencing the phenotype of normal and BCR/ABL-transformed myeloid progenitors.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, BLSB 630, 233 S. 10th St., Philadelphia, PA 19107. Phone: (215) 503-4524. Fax: (215) 923-0249. E-mail: Danilo.Perrotti{at}mail.tju.edu.

Molecular and Cellular Biology, April 2002, p. 2255-2266, Vol. 22, No. 7
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.7.2255-2266.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gao, Y., Howard, A., Ban, K., Chandra, J. (2009). Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells. J. Biol. Chem. 284: 7114-7125 [Abstract] [Full Text]  
  • Jablonski, J. A., Caputi, M. (2009). Role of Cellular RNA Processing Factors in Human Immunodeficiency Virus Type 1 mRNA Metabolism, Replication, and Infectivity. J. Virol. 83: 981-992 [Abstract] [Full Text]  
  • Motiwala, T., Majumder, S., Ghoshal, K., Kutay, H., Datta, J., Roy, S., Lucas, D. M., Jacob, S. T. (2009). PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells. J. Biol. Chem. 284: 455-464 [Abstract] [Full Text]  
  • Jo, O. D., Martin, J., Bernath, A., Masri, J., Lichtenstein, A., Gera, J. (2008). Heterogeneous Nuclear Ribonucleoprotein A1 Regulates Cyclin D1 and c-myc Internal Ribosome Entry Site Function through Akt Signaling. J. Biol. Chem. 283: 23274-23287 [Abstract] [Full Text]  
  • Spooncer, E., Brouard, N., Nilsson, S. K., Williams, B., Liu, M. C., Unwin, R. D., Blinco, D., Jaworska, E., Simmons, P. J., Whetton, A. D. (2008). Developmental Fate Determination and Marker Discovery in Hematopoietic Stem Cell Biology Using Proteomic Fingerprinting. Mol. Cell. Proteomics 7: 573-581 [Abstract] [Full Text]  
  • Eiring, A. M., Neviani, P., Santhanam, R., Oaks, J. J., Chang, J. S., Notari, M., Willis, W., Gambacorti-Passerini, C., Volinia, S., Marcucci, G., Caligiuri, M. A., Leone, G. W., Perrotti, D. (2008). Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood 111: 816-828 [Abstract] [Full Text]  
  • Cammas, A., Pileur, F., Bonnal, S., Lewis, S. M., Leveque, N., Holcik, M., Vagner, S. (2007). Cytoplasmic Relocalization of Heterogeneous Nuclear Ribonucleoprotein A1 Controls Translation Initiation of Specific mRNAs. Mol. Biol. Cell 18: 5048-5059 [Abstract] [Full Text]  
  • Chang, J. S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A. M., Briercheck, E., Ronchetti, M., Roy, D. C., Calabretta, B., Caligiuri, M. A., Perrotti, D. (2007). High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBP{alpha}-driven myeloid differentiation. Blood 110: 994-1003 [Abstract] [Full Text]  
  • Perrotti, D., Neviani, P. (2007). From mRNA Metabolism to Cancer Therapy: Chronic Myelogenous Leukemia Shows the Way. Clin. Cancer Res. 13: 1638-1642 [Abstract] [Full Text]  
  • Yang, Z., Chang, Y.-J., Miyamoto, H., Yeh, S., Yao, J. L., di Sant'Agnese, P. A., Tsai, M.-Y., Chang, C. (2007). Suppression of Androgen Receptor Transactivation and Prostate Cancer Cell Growth by Heterogeneous Nuclear Ribonucleoprotein A1 via Interaction with Androgen Receptor Coregulator ARA54. Endocrinology 148: 1340-1349 [Abstract] [Full Text]  
  • Guil, S., Long, J. C., Caceres, J. F. (2006). hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response. Mol. Cell. Biol. 26: 5744-5758 [Abstract] [Full Text]  
  • Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., Perrotti, D. (2006). A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107: 2507-2516 [Abstract] [Full Text]  
  • Allemand, E., Guil, S., Myers, M., Moscat, J., Caceres, J. F., Krainer, A. R. (2005). Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. USA 102: 3605-3610 [Abstract] [Full Text]  
  • Bonnal, S., Pileur, F., Orsini, C., Parker, F., Pujol, F., Prats, A.-C., Vagner, S. (2005). Heterogeneous Nuclear Ribonucleoprotein A1 Is a Novel Internal Ribosome Entry Site trans-Acting Factor That Modulates Alternative Initiation of Translation of the Fibroblast Growth Factor 2 mRNA. J. Biol. Chem. 280: 4144-4153 [Abstract] [Full Text]  
  • Soboleva, T. A., Jans, D. A., Johnson-Saliba, M., Baker, R. T. (2005). Nuclear-Cytoplasmic Shuttling of the Oncogenic Mouse UNP/USP4 Deubiquitylating Enzyme. J. Biol. Chem. 280: 745-752 [Abstract] [Full Text]  
  • Patry, C., Lemieux, B., Wellinger, R. J., Chabot, B. (2004). Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines. Molecular Cancer Therapeutics 3: 1193-1199 [Abstract] [Full Text]  
  • Pio, R., Zudaire, I., Pino, I., Castano, Z., Zabalegui, N., Vicent, S., Garcia-Amigot, F., Odero, M. D., Lozano, M. D., Garcia-Foncillas, J., Calasanz, M. J., Montuenga, L. M. (2004). {alpha}CP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant {alpha}CP-4a, Is Underexpressed in Lung Cancer. Cancer Res. 64: 4171-4179 [Abstract] [Full Text]  
  • Topisirovic, I., Guzman, M. L., McConnell, M. J., Licht, J. D., Culjkovic, B., Neering, S. J., Jordan, C. T., Borden, K. L. B. (2003). Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis. Mol. Cell. Biol. 23: 8992-9002 [Abstract] [Full Text]  
  • Patry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R., Chabot, B. (2003). Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines. Cancer Res. 63: 7679-7688 [Abstract] [Full Text]  
  • Nimmanapalli, R., Bali, P., O'Bryan, E., Fuino, L., Guo, F., Wu, J., Houghton, P., Bhalla, K. (2003). Arsenic Trioxide Inhibits Translation of mRNA of bcr-abl, Resulting in Attenuation of Bcr-Abl Levels and Apoptosis of Human Leukemia Cells. Cancer Res. 63: 7950-7958 [Abstract] [Full Text]  
  • Chen, H., Hewison, M., Hu, B., Adams, J. S. (2003). Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance. Proc. Natl. Acad. Sci. USA 100: 6109-6114 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»